Zacks.com on MSN1d
Pfizer Sells Remaining 7.3% Stake in Haleon for Around 3.3B
Pfizer PFE has sold off its remaining stake in consumer health company Haleon HLN to institutional investors and Haleon ...
Pfizer to sell entire Haleon stake
Pfizer will sell its remaining stake in British consumer healthcare group Haleon , the companies said on Tuesday.
Pfizer Offloads Its Last 7% Stake In Consumer Health Haleon For Over $3 Billion
Pfizer has completed its exit from Haleon, selling its entire stake for $3.1 billion. BlackRock's unit is now Haleon's ...
Pfizer (PFE) Bids Farewell to Haleon with $3.3B Final Stake Sale
Pfizer Inc. (PFE) agreed to sell its remaining stake worth $3.3 billion in Haleon PLC (HLN), marking its exit from the UK-based consumer ...
Fierce Pharma2d
Pfizer pockets roughly £2.5B as it shaves off final stake in consumer health spinoff Haleon
With Pfizer’s final stake sale in the bag, the two Big Pharma companies behind Haleon’s genesis have formally parted ways with the standalone consumer health giant. | After charting similar moves ...
Pfizer Sells Remaining 7.3% Haleon Shareholding for $3.25 Billion
Pfizer sold its entire 7.3% shareholding in London-listed consumer-health company Haleon for a net sum of 2.5 billion pounds ($3.25 billion). Pfizer sold 618 million shares for 385 pence each. The ...
Drug Store News2d
Pfizer reportedly raises $3.3B from sale of remaining Haleon stake
Pfizer reportedly offered about 618 million shares through a placement with investors, according to a Wednesday statement.
Pfizer exits Haleon stake after $3.2B share sale
Pfizer (PFE) stock in focus as the company sells its entire 7.3% stake in Haleon (HLN) for $3.24B. Read more here.
The Business Times2d
Pfizer sells entire Haleon stake for US$3.24 billion
Bengaluru] Drugmaker Pfizer has sold its entire stake in Haleon for about US$3.24 billion to institutional investors and the ...